Skip to main content
Daesung Microbiological Labs. Co. Ltd logo

Daesung Microbiological Labs. Co. Ltd — Investor Relations & Filings

Ticker · 036480 ISIN · KR7036480002 KO Manufacturing
Open in API
Filings indexed 126 across all filing types
Latest filing 2026-03-06 Audit Report / Informat…
Country KR South Korea
Listing KO 036480

About Daesung Microbiological Labs. Co. Ltd

https://eng.dsmbio.co.kr/

Daesung Microbiological Labs. Co., Ltd. is a company specializing in the development, manufacturing, and distribution of animal pharmaceuticals. Established in 1968, it is a leading vaccine manufacturer operating under KVGMP (Korean Veterinary Good Manufacturing Practice) standards. The company's product portfolio includes a comprehensive range of vaccines, antibiotics, parasiticides, and nutritional supplements. These products are designed for the health and well-being of livestock such as swine, bovine, and poultry, as well as for companion animals like canines. Daesung Microbiological Labs is committed to achieving disease-free livestock through continuous research and technological innovation in animal health.

Recent filings

Filing Released Lang Actions
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from a Korean company (Daesung Microbiological Labs) regarding a correction to a previously filed report on changes in financial structure (sales or profit/loss). It details specific line-item adjustments to operating profit, net income, and assets due to the external audit process. This falls under the category of general regulatory announcements or filings that provide updates on financial disclosures, which is best classified as RNS (Regulatory Filings) as it is a specific regulatory disclosure form. FY 2025
2026-03-06 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from a Korean company (Daesung Microbiological Labs) announcing a significant change in financial structure (revenue/profit/loss) exceeding 15% for a large corporation or 30% for others. This is a standard 'Earnings Release' (ER) format used in the Korean market (DART system) to provide preliminary financial highlights before the final audited annual report is published. FY 2025
2026-02-04 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from Daesung Microbiological Labs regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected date of the shareholder meeting for approval. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2026-02-04 Korean
[기재정정]영업실적등에대한전망(공정공시)
Earnings Release Classification · 1% confidence The document is a regulatory filing from Daesung Microbiological Labs regarding a correction to a previously disclosed earnings forecast (Fair Disclosure/Gongjeong-gongsi). It details the revision of 2025 revenue and operating profit projections. Since this is a specific regulatory announcement regarding financial guidance updates rather than a full report, conference call, or dividend notice, it falls under the general regulatory filing category. FY 2025
2026-02-03 Korean
영업실적등에대한전망(공정공시)
Earnings Release Classification · 1% confidence The document is a 'Fair Disclosure' (공정공시) filing from Daesung Microbiological Labs regarding their earnings forecast for the 2025 fiscal year. It provides specific revenue and operating profit projections based on internal estimates. Since this is a regulatory disclosure of financial guidance rather than a full quarterly report, an earnings release, or a report publication announcement, it falls under the general regulatory filing category. FY 2025
2026-01-13 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Daesung Microbiological Labs regarding a 'Single Sale/Supply Contract' amendment. It details a contract extension for government procurement of animal vaccines. Since this is a specific regulatory announcement regarding a business contract and does not fit into categories like financial reports, dividends, or M&A, it falls under the general regulatory filing category.
2025-12-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.